Tomotherapy's Hi-Art System.


June 9, 2010 - As the competition heats up in the radiation therapy systems market, Tomotherapy Inc. announced today that it has signed an equipment supply group purchasing agreement with group purchasing organization (GPO) MedAssets.

The GPO will gain access to the Tomotherapy technology, an form of advanced radiation therapy, through an expanded radiation oncology portfolio. MedAssets is one of the largest group purchasing organizations in the United States, utilizing a national contract portfolio of more than 1,500 contracts to efficiently connect manufacturers, distributors and other suppliers with its more than 1,700 hospitals and over 40,000 nonacute health care provider customers.

“MedAssets is a well-respected organization with expertise in supply chain consulting. We are honored to partner with them, and confident our collaboration with MedAssets will open doors to new institutions seeking an innovative radiation oncology solution,” said Ralph Vaello, TomoTherapy’s chief commercial officer.

For more information: www.tomotherapy.com and www.medassets.com


Related Content

News | FDA

Dec. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced ...

Time December 04, 2025
arrow
News | Interventional Radiology

Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...

Time November 13, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
News | Prostate Cancer

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
News | Lung Imaging

Nov. 3, 2025 — RevealDx, a leader in the characterization of lung nodules, has introduced MDR Certification of RevealAI ...

Time November 07, 2025
arrow
News | Artificial Intelligence

Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...

Time November 07, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Prostate Cancer

Sept. 30, 2025 – EDAP TMS's non-invasive, nonsurgical treatment option, Focal One Robotic HIFU, was featured on national ...

Time September 30, 2025
arrow
Subscribe Now